Chandra Viswanathan

1.5k total citations
42 papers, 1.1k citations indexed

About

Chandra Viswanathan is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Chandra Viswanathan has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 17 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Chandra Viswanathan's work include Mesenchymal stem cell research (19 papers), Pluripotent Stem Cells Research (11 papers) and Tissue Engineering and Regenerative Medicine (11 papers). Chandra Viswanathan is often cited by papers focused on Mesenchymal stem cell research (19 papers), Pluripotent Stem Cells Research (11 papers) and Tissue Engineering and Regenerative Medicine (11 papers). Chandra Viswanathan collaborates with scholars based in India and United States. Chandra Viswanathan's co-authors include Anish Sen Majumdar, Deepa Ghosh, J. Ramanathan, M B Agarwal, R.R. Puniyani, Ajay Kumar, Anup Kumar Das, Ashish Mehta, Balaji Bandyopadhyay and Meera Venkatesh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Carbohydrate Polymers.

In The Last Decade

Chandra Viswanathan

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chandra Viswanathan India 16 580 296 270 189 159 42 1.1k
Regina Brunauer United States 14 486 0.8× 296 1.0× 355 1.3× 150 0.8× 63 0.4× 33 1.2k
Zhifeng Gu China 22 520 0.9× 234 0.8× 683 2.5× 291 1.5× 70 0.4× 86 1.7k
Fengjuan Lv China 8 555 1.0× 338 1.1× 327 1.2× 58 0.3× 40 0.3× 11 1.0k
Alexandra Sémont France 17 696 1.2× 297 1.0× 272 1.0× 82 0.4× 40 0.3× 20 1.2k
Adrian Băican Romania 9 283 0.5× 129 0.4× 228 0.8× 335 1.8× 105 0.7× 32 1.2k
Susanne Schatz Germany 4 245 0.4× 181 0.6× 266 1.0× 346 1.8× 81 0.5× 4 1.1k
Wolf Christian Prall Germany 22 321 0.6× 652 2.2× 384 1.4× 66 0.3× 78 0.5× 60 1.6k
Kwang‐Won Seo South Korea 17 431 0.7× 181 0.6× 399 1.5× 151 0.8× 27 0.2× 26 959
Xiuli Ju China 18 265 0.5× 167 0.6× 549 2.0× 253 1.3× 188 1.2× 78 1.2k

Countries citing papers authored by Chandra Viswanathan

Since Specialization
Citations

This map shows the geographic impact of Chandra Viswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra Viswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra Viswanathan more than expected).

Fields of papers citing papers by Chandra Viswanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandra Viswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra Viswanathan. The network helps show where Chandra Viswanathan may publish in the future.

Co-authorship network of co-authors of Chandra Viswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Chandra Viswanathan. A scholar is included among the top collaborators of Chandra Viswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandra Viswanathan. Chandra Viswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Anup Kumar, et al.. (2015). Preparation and characterization of silver nanoparticle loaded amorphous hydrogel of carboxymethylcellulose for infected wounds. Carbohydrate Polymers. 130. 254–261. 75 indexed citations
2.
Viswanathan, Chandra, et al.. (2015). Long-term culture and cryopreservation does not affect the stability and functionality of human embryonic stem cell-derived hepatocyte-like cells. In Vitro Cellular & Developmental Biology - Animal. 52(2). 243–251. 5 indexed citations
3.
Viswanathan, Chandra, et al.. (2014). Natural killer cells. Hematology/Oncology and Stem Cell Therapy. 8(2). 47–55. 204 indexed citations
4.
Viswanathan, Chandra, et al.. (2014). Paracrine Factors Secreted by Umbilical Cord-Derived Mesenchymal Stem Cells Induce Angiogenesis In Vitro by a VEGF-Independent Pathway. Stem Cells and Development. 24(4). 437–450. 72 indexed citations
5.
Viswanathan, Chandra, et al.. (2014). Transplantation of autologous ex vivo expanded human conjunctival epithelial cells for treatment of pterygia: A prospective open-label single arm multicentric clinical trial. Journal of Ophthalmic and Vision Research. 9(4). 407–407. 11 indexed citations
6.
Menghani, Ekta, et al.. (2013). Defining Permissible Time Lapse between Umbilical Cord Tissue Collection and Commencement of Cell Isolation. SHILAP Revista de lepidopterología. 1 indexed citations
8.
Viswanathan, Chandra, et al.. (2013). Status of Stem Cell Based Clinical Trials in the Treatment for Diabetes. Current Diabetes Reviews. 9(6). 429–436. 6 indexed citations
9.
Mukherjee, Archana, et al.. (2012). Radiolabeling of Umbilical Cord-Derived Mesenchymal Stem Cells for In Vivo Tracking. Cancer Biotherapy and Radiopharmaceuticals. 27(9). 614–619. 11 indexed citations
11.
Bandyopadhyay, Balaji, et al.. (2012). In vitro and in vivo evaluation of L‐lactide/ε‐caprolactone copolymer scaffold to support myoblast growth and differentiation. Biotechnology Progress. 29(1). 197–205. 13 indexed citations
12.
Viswanathan, Chandra, et al.. (2010). Derivation, characterization, and gene expression profile of two new human ES cell lines from India. Stem Cell Research. 5(3). 173–187. 8 indexed citations
13.
Ghosh, Deepa, et al.. (2010). Immunologic properties of human dermal fibroblasts. Human Immunology. 71(11). 1089–1098. 6 indexed citations
14.
Mehta, Ashish, et al.. (2010). Molecular and cellular characterization of expanded and cryopreserved human limbal epithelial stem cells reveal unique immunological properties. Experimental Eye Research. 92(1). 47–56. 15 indexed citations
15.
Viswanathan, Chandra, et al.. (2010). Derivation, Expansion and Characterization of Clinical Grade Mesenchymal Stem Cells from Umbilical Cord Matrix Using Cord Blood Serum. International Journal of Stem Cells. 3(2). 119–128. 16 indexed citations
16.
Viswanathan, Chandra, et al.. (2009). Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease. Cell Biology International. 33(8). 830–838. 38 indexed citations
17.
Viswanathan, Chandra, et al.. (2009). India’s first public cord blood repository — looking back and moving forward. Indian Journal of Hematology and Blood Transfusion. 25(3). 111–117. 5 indexed citations
18.
Viswanathan, Chandra, et al.. (2008). One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochemical and Biophysical Research Communications. 373(2). 258–264. 32 indexed citations
19.
Viswanathan, Chandra. (2001). Are our donors safe?. The Indian Journal of Pediatrics. 68(1). 69–75. 4 indexed citations
20.
Agarwal, M B, et al.. (1992). Long‐term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial. British Journal of Haematology. 82(2). 460–466. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026